Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-063669
Filing Date
2025-03-26
Accepted
2025-03-26 11:56:46
Documents
5
Period of Report
2025-03-26

Document Format Files

Seq Description Document Type Size
1 6-K d939010d6k.htm 6-K 8959
2 EX-99.1 d939010dex991.htm EX-99.1 23654
3 EX-99.2 d939010dex992.htm EX-99.2 15680
4 GRAPHIC g939010g01m04.jpg GRAPHIC 6100
5 GRAPHIC g939010image2.jpg GRAPHIC 1440
  Complete submission text file 0001193125-25-063669.txt   60164
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 25771229
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)